Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Geoff Meacham is an analyst at B of A Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/28/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 06/27/2024 | LYEL | Buy Now | Lyell Immunopharma | $1.39 | 331.59% | $9 → $6 | Maintains | Buy | Get Alert |
| 06/25/2024 | BBIO | Buy Now | BridgeBio Pharma | $25.32 | 65.88% | $50 → $42 | Maintains | Buy | Get Alert |
| 06/24/2024 | LLY | Buy Now | Eli Lilly and Co | $906.04 | 10.37% | $1000 → $1000 | Maintains | Buy | Get Alert |
| 06/13/2024 | RNA | Buy Now | Avidity Biosciences | $40.88 | 10.08% | $40 → $45 | Maintains | Buy | Get Alert |
| 05/10/2024 | APGE | Buy Now | Apogee Therapeutics | $39.35 | 103.3% | → $80 | Initiates | → Buy | Get Alert |
| 05/03/2024 | RNA | Buy Now | Avidity Biosciences | $40.88 | -2.15% | → $40 | Initiates | → Buy | Get Alert |
| 04/17/2024 | JNJ | Buy Now | Johnson & Johnson | $146.28 | 16.22% | $180 → $170 | Maintains | Neutral | Get Alert |
| 04/12/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.05K | -31.5% | $710 → $720 | Maintains | Underperform | Get Alert |
| 04/12/2024 | RPRX | Buy Now | Royalty Pharma | $26.37 | 44.1% | $40 → $38 | Maintains | Buy | Get Alert |
| 04/12/2024 | BIIB | Buy Now | Biogen | $231.82 | 12.16% | $280 → $260 | Maintains | Neutral | Get Alert |
| 03/13/2024 | BTAI | Buy Now | BioXcel Therapeutics | $1.32 | 430.3% | $8 → $7 | Maintains | Buy | Get Alert |
| 03/13/2024 | JANX | Buy Now | Janux Therapeutics | $41.89 | 14.59% | $24 → $48 | Maintains | Buy | Get Alert |
| 03/01/2024 | LLY | Buy Now | Eli Lilly and Co | $906.04 | 10.37% | $800 → $1000 | Maintains | Buy | Get Alert |
| 02/07/2024 | LLY | Buy Now | Eli Lilly | $906.04 | -10.6% | $680 → $810 | Maintains | Overweight | Get Alert |
| 01/03/2024 | KYMR | Buy Now | Kymera Therapeutics | $29.85 | 0.5% | $45 → $30 | Downgrade | Buy → Neutral | Get Alert |
| 01/03/2024 | LIAN | Buy Now | LianBio | — | — | $5 → $3 | Downgrade | Buy → Underperform | Get Alert |
| 01/03/2024 | BMY | Buy Now | Bristol-Myers Squibb | $41.62 | 44.16% | $68 → $60 | Downgrade | Buy → Neutral | Get Alert |
| 12/27/2023 | BMY | Buy Now | Bristol-Myers Squibb | $41.62 | 63.38% | $72 → $68 | Maintains | Buy | Get Alert |
| 12/15/2023 | IGMS | Buy Now | IGM Biosciences | $6.87 | 16.45% | → $8 | Downgrade | Buy → Neutral | Get Alert |
| 10/11/2023 | AMGN | Buy Now | Amgen | $312.45 | -7.19% | → $290 | Reinstates | → Neutral | Get Alert |
| 10/10/2023 | NMRA | Buy Now | Neumora Therapeutics | $9.83 | 83.11% | → $18 | Initiates | → Buy | Get Alert |
| 09/08/2023 | VIR | Buy Now | Vir Biotechnology | $8.76 | 59.82% | $23 → $14 | Downgrade | Buy → Neutral | Get Alert |
| 09/08/2023 | GILD | Buy Now | Gilead Sciences | $68.65 | 38.38% | $88 → $95 | Upgrade | Neutral → Buy | Get Alert |
| 08/21/2023 | CVAC | Buy Now | CureVac | $3.37 | 137.39% | $10 → $8 | Maintains | Underperform | Get Alert |
| 08/21/2023 | RANI | Buy Now | Rani Therapeutics Hldgs | $4.00 | 325% | $19 → $17 | Maintains | Buy | Get Alert |
| 08/15/2023 | TSBX | Buy Now | Turnstone Biologics | $2.66 | 576.67% | → $18 | Initiates | → Buy | Get Alert |
| 08/04/2023 | MRNA | Buy Now | Moderna | $118.80 | 26.26% | $175 → $150 | Maintains | Neutral | Get Alert |
| 07/28/2023 | BMY | Buy Now | Bristol-Myers Squibb | $41.62 | 92.22% | $85 → $80 | Maintains | Buy | Get Alert |
| 07/21/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $82.33 | 124.71% | $200 → $185 | Maintains | Buy | Get Alert |
| 07/20/2023 | ABOS | Buy Now | Acumen Pharmaceuticals | $2.42 | 478.51% | → $14 | Reinstates | → Buy | Get Alert |
| 05/23/2023 | ICPT | Buy Now | Intercept Pharma | — | — | $17 → $14 | Maintains | Underperform | Get Alert |
| 05/04/2023 | BIIB | Buy Now | Biogen | $231.82 | 38.04% | $300 → $320 | Maintains | Neutral | Get Alert |
| 04/21/2023 | PFE | Buy Now | Pfizer | $27.97 | 60.89% | $50 → $45 | Maintains | Neutral | Get Alert |
| 04/21/2023 | BMY | Buy Now | Bristol-Myers Squibb | $41.62 | 104.23% | $82 → $85 | Maintains | Buy | Get Alert |
| 04/21/2023 | BIIB | Buy Now | Biogen | $231.82 | 29.41% | $295 → $300 | Maintains | Neutral | Get Alert |
| 02/23/2023 | GRPH | Buy Now | Graphite Bio | — | — | $21 → $14 | Downgrade | Neutral → Underperform | Get Alert |
| 01/18/2023 | GRPH | Buy Now | Graphite Bio | — | — | $49 → $21 | Downgrade | Buy → Neutral | Get Alert |
| 01/05/2023 | AMLX | Buy Now | Amylyx Pharma | $1.90 | 2531.58% | → $50 | Initiates | → Buy | Get Alert |
| 01/04/2023 | MRK | Buy Now | Merck & Co | $125.00 | 4% | $110 → $130 | Upgrade | Neutral → Buy | Get Alert |
| 01/04/2023 | PFE | Buy Now | Pfizer | $27.97 | 114.52% | → $60 | Downgrade | Buy → Neutral | Get Alert |
| 12/14/2022 | ABBV | Buy Now | AbbVie | $170.75 | -3.37% | $162 → $165 | Maintains | Neutral | Get Alert |
| 12/13/2022 | GILD | Buy Now | Gilead Sciences | $68.65 | 23.82% | → $85 | Reinstates | → Neutral | Get Alert |
| 12/05/2022 | ABBV | Buy Now | AbbVie | $170.75 | -5.12% | $160 → $162 | Maintains | Neutral | Get Alert |
| 11/01/2022 | INO | Buy Now | Inovio Pharmaceuticals | $8.25 | -75.76% | → $24 | Downgrade | Neutral → Underperform | Get Alert |
| 10/03/2022 | ICPT | Buy Now | Intercept Pharma | — | — | $16 → $14 | Maintains | Underperform | Get Alert |
| 08/29/2022 | IGMS | Buy Now | IGM Biosciences | $6.87 | 394.91% | → $34 | Initiates | → Buy | Get Alert |
| 07/07/2022 | LLY | Buy Now | Eli Lilly | $906.04 | -60.82% | $333 → $355 | Maintains | Overweight | Get Alert |
| 06/21/2022 | ABBV | Buy Now | AbbVie | $170.75 | -8.64% | → $156 | Reiterates | → Neutral | Get Alert |
| 06/08/2022 | OMER | Buy Now | Omeros | $4.06 | -1.48% | $12 → $4 | Downgrade | Buy → Neutral | Get Alert |
| 04/22/2022 | ABBV | Buy Now | AbbVie | $170.75 | -8.64% | $152 → $156 | Maintains | Neutral | Get Alert |
| 03/28/2022 | BIIB | Buy Now | Biogen | $231.82 | -2.94% | $230 → $225 | Maintains | Neutral | Get Alert |
| 03/17/2022 | ABBV | Buy Now | AbbVie | $170.75 | -10.98% | $145 → $152 | Maintains | Neutral | Get Alert |
| 02/03/2022 | ABBV | Buy Now | AbbVie | $170.75 | -19.18% | $135 → $138 | Maintains | Neutral | Get Alert |
| 01/21/2022 | CVAC | Buy Now | CureVac | $3.37 | 493.47% | $55 → $20 | Downgrade | Neutral → Underperform | Get Alert |
| 01/21/2022 | ABOS | Buy Now | Acumen Pharmaceuticals | $2.42 | 478.51% | $16 → $14 | Upgrade | Neutral → Buy | Get Alert |
| 01/21/2022 | INO | Buy Now | Inovio Pharmaceuticals | $8.25 | 21.21% | $96 → $120 | Upgrade | Underperform → Neutral | Get Alert |
| 01/21/2022 | MRNA | Buy Now | Moderna | $118.80 | 51.52% | $135 → $180 | Upgrade | Underperform → Neutral | Get Alert |
| 01/05/2022 | AMGN | Buy Now | Amgen | $312.45 | -18.39% | $285 → $255 | Downgrade | Buy → Neutral | Get Alert |
| 01/05/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.05K | -45.29% | $675 → $575 | Downgrade | Neutral → Underperform | Get Alert |
| 01/05/2022 | PFE | Buy Now | Pfizer | $27.97 | 150.27% | $59 → $70 | Upgrade | Neutral → Buy | Get Alert |
| 12/29/2021 | KNSA | Buy Now | Kiniksa Pharmaceuticals | $18.67 | 82.11% | $37 → $34 | Maintains | Buy | Get Alert |
| 12/23/2021 | BIIB | Buy Now | Biogen | $231.82 | 18.63% | $295 → $275 | Maintains | Neutral | Get Alert |
| 12/06/2021 | VAXX | Buy Now | Vaxxinity | $0.25 | 8316.83% | — | Initiates | → Buy | Get Alert |
| 09/10/2021 | INO | Buy Now | Inovio Pharmaceuticals | $8.25 | -3.03% | $108 → $96 | Downgrade | Neutral → Underperform | Get Alert |
| 08/02/2021 | ABBV | Buy Now | AbbVie | $170.75 | -30.31% | $115 → $119 | Maintains | Neutral | Get Alert |
| 07/20/2021 | GRPH | Buy Now | Graphite Bio | — | — | → $245 | Initiates | → Buy | Get Alert |
| 05/19/2021 | ABBV | Buy Now | AbbVie | $170.75 | -33.82% | $110 → $113 | Maintains | Neutral | Get Alert |
| 05/07/2021 | YMAB | Buy Now | Y-mAbs Therapeutics | $12.08 | 363.58% | → $56 | Upgrade | Neutral → Buy | Get Alert |
| 03/23/2021 | INO | Buy Now | Inovio Pharmaceuticals | $8.25 | 57.58% | → $156 | Initiates | → Neutral | Get Alert |
| 01/05/2021 | ICPT | Buy Now | Intercept Pharma | — | — | $55 → $40 | Maintains | Neutral | Get Alert |
| 12/11/2020 | ABBV | Buy Now | AbbVie | $170.75 | -35.58% | $97 → $110 | Maintains | Neutral | Get Alert |
| 10/07/2020 | YMAB | Buy Now | Y-mAbs Therapeutics | $12.08 | 280.79% | $48 → $46 | Upgrade | Neutral → Buy | Get Alert |
| 12/20/2018 | DBVT | Buy Now | DBV Technologies | $0.80 | 900% | $60 → $16 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 10/23/2017 | DBVT | Buy Now | DBV Technologies | $0.80 | 3650% | $116 → $60 | Maintains | Overweight | Get Alert |
| 12/03/2015 | DBVT | Buy Now | DBV Technologies | $0.80 | 7150% | → $116 | Initiates | → Overweight | Get Alert |
